Alpine Associates Management’s Vigil Neuroscience VIGL Stock Holding History

Alpine Associates Management’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,094,900	Closed	-$8.7M	–	97
2025 Q2	$8.7M	Buy	+1,094,900	New	+$4.91M	0.46%	44

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Alpine Associates Management's VIGL Position: Q3 2025 in Review

Alpine Associates Management sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 1,094,900 shares — an estimated $8.7M sold.

Alpine Associates Management first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $8.7M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Alpine Associates Management reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Alpine Associates Management sold 1,094,900 Vigil Neuroscience shares in Q3 2025, an estimated $8.7M.
Alpine Associates Management first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Alpine Associates Management's Vigil Neuroscience position peaked at $8.7M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Alpine Associates Management's 13F filing for Q3 2025, filed 6 Nov 2025.